EDIT Q1 2020 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+176.6% YoY

Gross Profit

-$29M-504.1% margin

Operating Income

-$47M-814.5% margin

Net Income

-$38M-659.2% margin

EPS (Diluted)

$-0.69

QoQ Revenue Growth

-53.4%

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$56M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$467M

Total Liabilities

$232M

Stockholders' Equity

$235M

Cash & Equivalents

$233M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$2M	+176.6%
Gross Profit	-$29M	-$14M	-109.4%
Operating Income	-$47M	-$31M	-49.1%
Net Income	-$38M	-$29M	-29.0%